在卵巢癌中,GANT61调节自和脂质代谢
Yibin Pan1,2,3, Lingfeng Chen1,2,3,4, Jinlu Shen1,2,3
1Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Cell proliferation
|May 1, 2025
概括
GANT61通过AKT/SREBP1通路触发了自和脂质滴积累. 将GANT61与CQ/Fatostatin结合使用,可以有效地抑制癌细胞生长和克隆性.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 生物化学 生物化学
背景情况:
- 自在癌症中起着复杂的作用,影响细胞生存和耐药性.
- 脂质代谢越来越被认为是癌症进展和治疗脆弱性的关键因素.
研究的目的:
- 研究GANT61对癌细胞自和脂质代谢的影响.
- 阐明GANT61诱导的细胞变化背后的分子机制.
- 评估GANT61与其他药物结合对癌细胞增殖的协同效应.
主要方法:
- 使用的细胞系是SKOV3和SKOV3PTX.
- 研究了AKT通路和醇调控元素结合蛋白1 (SREBP1) 的作用.
- 评估了单独使用GANT61以及与CQ/Fatostatin结合使用的GANT61对增殖和克隆原性的影响.
主要成果:
- GANT61诱导了自,并通过AKT通路促进了脂质滴积累.
- 确定SREBP1是GANT61诱导的脂质积累的调解者.
- GANT61与CQ/Fatostatin的组合显著抑制了两种细胞系中的增殖和克隆性.
结论:
- GANT61通过AKT/SREBP1轴调节癌细胞中的自和脂质代谢.
- 用GANT61和CQ/Fatostatin联合抑制自和脂质代谢,为对抗SKOV3和SKOV3PTX细胞提供了一个有前途的治疗策略.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.6K
07:20Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
356
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
